Major challenge for tablet and capsule manufacturing comes physico-mechanical properties required for the from the flow properties of the materials to be compressed. development of robust directly compressed product, which Poor flow of the materials poses challenges in terms of can be scaled up smoothly 3 . Hence, there is a need to achieving requisite quality parameters, greater productivity, have excipients with multiple characteristics built into them and in turn, economy. Despite enormous improvements in such as better flow, low/no moisture sensitivity, superior wet granulation techniques, tablet manufacture by direct compressibility and rapid disintegration ability 4 compression technique has increased steadily over the years. The major reason for this being, new molecules are New combinations of existing excipients are an more sensitive to moisture, oxidation or heat. It has been interesting option for improving the overall characteristics reported in a survey conducted in 1992 that direct of the material, which is to be compressed. Excipient compression is the preferred method of compression used mixtures prepared by co-processing have improved by a of majority of the manufacturers 1 . Further, use of functionality as compared to simple physical blends 5 . The
. these "co-processed" excipients in spray-dried form has also given a much-needed impetus to this technology.
The conventional method of wet granulation has inherent drawbacks in terms of achieving batch-to-batch reproducibility and higher productivity, especially in low particle size range. Compared to wet granulation, direct compression requires fewer processing steps, offers simplified validation and results in product with better stability 2 . Tablets consist of active drugs and excipients. A single drug or excipient does not possess all the desired *For correspondence E-mail: amavachat@yahoo.com development of these single bodied excipients known as co-processed excipients has gained importance in the last decade 6 . The compaction properties of mixtures have been reviewed by Fell 7 , who concluded that the relationship between the tabletting properties of a mixture could only rarely be predicted from knowledge of the same properties of the individual components 8 . Many co processed brands of excipients are in use today, which contain a blend of excipients which interact with each other at the sub particle level resulting in a synergy of improved functionality, whereby it can mask the undesirable properties of the individual excipients. Spray drying normally imparts improved flow and compressibility characteristics to excipients. www.ijpsonline.com
The present investigation was aimed at evaluating and characterizing two co-processed spray dried materials comprising of microcrystalline cellulose and other excipients. This co-processed blend consists of individual materials having filler, binder and disintegrant characteristics. Use of such a product also reduces the cost of final formulation. These materials were then used along with different drugs to make tablets by direct compression and compared with the tablets obtained from conventional method of manufacture as well as with marketed preparations.
Development of prototype formulations:
To check the performance of co-processed materials for direct compression some prototype formulations were prepared and comparison was made with conventional formulations. Three different active ingredients viz. amoxycillin, iron polymaltose, diclofenac sodium were chosen for the study due to their specific properties. Amoxycillin is used as dispersible tablets. Due to the high dose requirement and sticky nature of amoxycillin it is difficult to make a formulation with ultra low dispersion time. Iron polymaltose has high dose and is highly water-
MATERIALS AND METHODS
soluble. Due to its high solubility, the tablet disintegrates by erosion and not by explosion. Diclofenac sodium is a Ran Explo-C; consisting of microcrystalline cellulose, low dose product and can be made by direct colloidal silicon dioxide, crospovidone and Ran Explo-S; compression method. consisting of microcrystalline cellulose, colloidal silicon dioxide and sodium starch glycollate; in the spray-dried All the formulations were studied for granule properties form were obtained as gift samples from M/S RanQ important for flowability. The compressed tablets were Pharmaceuticals and Excipients Ltd., Nashik. Diclofenac also evaluated for various physical parameters. sodium, iron polymaltose complex and amoxycillin Formulation details of each product, along with evaluation trihydrate were obtained from Noble Drugs, Nashik. data are given in Tables 2-7 . Magnesium stearate, talc, starch, mannitol, colloidal silicon dioxide, microcrystalline cellulose and sodium saccharine Brief manufacturing process for amoxycillin were obtained as gift samples from Blue Cross tablets: Laboratories, Nashik.
Formulation A and B were prepared by blending weighed amounts of amoxycillin (30#) and Ran Explo-C Evaluation of physicochemical properties of coor Ran Explo-S with lubricants, sweeteners and flavours processed materials:
in a tumbling mixer for 15 min. The prepared blend was Two directly compressible co-processed materials Ran compressed into tablets using 11.2 mm FFBE punch on a Explo-C and Ran Explo-S were evaluated for their flow 10 station rotary machine (direct compression). properties (Table 1) , like angle of repose, bulk density, tapped density, Carr's compressibility index and Hausner's Formulation C was prepared using the following ratio using well-established methods [9] [10] [11] . Angle of repose procedure; weighed amounts of starch and MCC were was determined using reposograph. Bulk density, tapped granulated using starch paste. The cohesive mass was as well as untapped, was determined using bulk density then passed through 10# sieve. The resultant wet apparatus and particle size distribution was done by sieve granules were subjected to tray drying for one hour at analysis using standard sieves i.e. 40#, 60#, 85# and 120#.
60°. The dried granules were then passed through 30# This '#' indicates the sieve used for evaluation of excipients sieve. The dummy granules so obtained were blended with amoxycillin (30#), lubricants, sweeteners and flavours. The blend was compressed into tablets using 11.2 mm FFBE punch on a 10 station rotary machine (conventional method, wet granulation). The details of the formulation are given in Table 2 .
Brief manufacturing process for iron polymaltose tablets:
Formulation A and B were prepared by blending weighed amounts of iron polymaltose (30#) and Ran Explo-C or Ran Explo-S with the lubricants, sweeteners and flavours in a tumbling mixer for 15 min. The prepared blend was compressed into tablets using 11.2 www.ijpsonline.com mm FFBE punch on a 10 station rotary machine (direct compression).
Formulation C was prepared as follows; weighed amount of mannitol was granulated using starch paste. The cohesive mass was then passed through 10# sieve. The resultant wet granules were subjected to tray drying for one hour at 60°. The dried granules were then passed through 22# sieve. The dummy granules so obtained were blended with iron polymaltose (30#), lubricants, sweeteners and flavours. The blend was compressed into tablets using 12.5 mm FFBE punch on a 10 station rotary machine (conventional method, wet granulation). The details of the formulation are given in Table 3 .
Brief manufacturing process for diclofenac sodium tablets:
Formulation A and B were prepared by blending weighed amounts of diclofenac sodium and Ran Explo-C or Ran Explo-S with the lubricants in a tumbling mixer for 15 min. The prepared blend was compressed into tablets using 8.00 mm FFBE punch on a 10 station rotary machine (direct compression).
Formulation C was prepared as follows. Granules of diclofenac sodium were prepared by wet granulation technique using starch paste after premixing it with microcrystalline cellulose. The granules were dried and sized by passing through 22# sieve. Dried granules were www.ijpsonline.com 
Marketed tablets (D)
Angle of repose Hausner's ratio Sieve analysis then blended with the lubricants. The tablets were compressed using 10-station rotary machine using 8.0-mm FFBE punches. The details of the formulation are given in Table 4 .
Evaluation of tablets:
Hardness was determined using Monsanto hardness tester, while friability was done in Roche friabilator. Disintegration test was performed in a disintegration test apparatus (Model: Eectrolab, Mumbai) at 37° in 900 ml water for iron polymaltose and diclofenac sodium tablets. Dispersible tablets of amoxycillin were subjected to disintegration test in water at 25° according to wellestablished methods 12 . Dissolution studies were carried out using dissolution test apparatus (Model: LabIndia,) using apparatus-1 as per well-established techniques.
RESULTS AND DISCUSSION
Ran Explo-C and Ran Explo-S are very fine free flowing co-processed materials as can be observed from Table 1 . The values of Carr's compressibility index between 5 15% indicate excellent flow 13 . Both Ran Explo-C and Ran Explo-S are having a particle size distribution which shows that 90% of the material has particle size less than 60#, indicating the fine nature of the material. Low angle www.ijpsonline.com This '#' indicates the sieve used for evaluation of granules of repose (<30°), Hausner's ratio of less than 1.3 and exposed area and still have improved properties. Friability Carr's compressibility index of less than 25% indicate the values also indicate better results as compared to excellent flow properties of these materials in spite of the conventionally made tablets (Table 6 ). fine particle size. This is achieved predominantly because of spray drying process.
Diclofenac sodium tablets showed improved characteristics with respect to disintegration time and friability for the One of the objectives of the study was to investigate same given hardness of the tablets, as can be observed in these spray-dried materials as directly compressible filler- Table 7 . Prototype formulations thus produced using co disintegrant-suspending agents by incorporating them with processed materials showed, superior compressibility, some of the model drugs. Tablets of amoxycillin made by excellent binding properties resulting in very low direct compression using Ran Explo-C and Ran Explo-S friability, low disintegration time, faster rate of dissolution showed very short disintegration time as compared to the and a fine dispersion, which was achieved on tablets made by conventional method of granulation. Even disintegration of tablets. at the same hardness, disintegration was less, specifically with Ran Explo-C. The tablets also passed uniformity of Commercially available microcrystalline cellulose (MCC) dispersion test (IP) indicating that it can be conveniently has the required directly compressible characteristics but incorporated in dispersible tablets. The marketed it fails to provide the disintegration and suspending preparation had lower hardness but still its disintegration properties required specifically for its use in dispersible time was comparable with tablets made with Ran Explo-C or Ran Explo-S. The tablets prepared using Ran Explo-C and Ran Explo-S, also had better suspendibility of the drug particles upon disintegration, which is an essential requisite of a dispersible tablet since they have to be administered to pediatric patients without losing the dose in the spoon (Table 5) .
Tablets of iron polymaltose made by direct compression with Ran Explo-C and Ran Explo-S showed a drastic reduction in disintegration time as compared to marketed preparation as well to those made in-house by conventional granulation method. It is also indicated that the tablets can be compressed at a lower diameter resulting in a smaller tablets. Prosolv (Pen West Pharmaceuticals) is a commercially available co-processed excipient comprising of MCC and silicon dioxide having better flow and compressibility but lacking in disintegration ability and suspendibility. As compared to it, the investigated co processed excipients additionally contain sodium starch glycollate/crospovidone which are proven superdisintegrants. Incorporation of these imparted additional property of disintegrability and suspendibility to the co-processed excipients.
These materials can be an ideal choice for making, tablets containing low dose medicament using direct compression technique, as well as dispersible tablets with low www.ijpsonline.com dispersion time at high tablet hardness and moderate to high drug content. They can also be a good substitute for inert/dummy granules, which are normally used in tablet manufacturing.
